News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,605 Results
Type
Article (7916)
Company Profile (35)
Press Release (136654)
Section
Business (43485)
Career Advice (239)
Deals (5205)
Drug Delivery (15)
Drug Development (21223)
Employer Resources (35)
FDA (2580)
Job Trends (3620)
News (71989)
Policy (5202)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (908)
Adcomms (3)
Allergies (22)
Alliances (12027)
ALS (26)
Alzheimer's disease (538)
Antibody-drug conjugate (ADC) (19)
Approvals (2582)
Artificial intelligence (70)
Autoimmune disease (3)
Automation (5)
Bankruptcy (31)
Best Places to Work (3200)
BIOSECURE Act (1)
Biosimilars (17)
Biotechnology (23)
Bladder cancer (19)
Brain cancer (8)
Breast cancer (87)
Cancer (578)
Cardiovascular disease (70)
Career advice (222)
Career pathing (8)
CAR-T (39)
Cell therapy (104)
Cervical cancer (2)
Clinical research (16536)
Collaboration (224)
Compensation (26)
Complete response letters (3)
COVID-19 (696)
CRISPR (18)
C-suite (86)
Cystic fibrosis (35)
Data (719)
Denatured (1)
Depression (10)
Diabetes (58)
Diagnostics (1540)
Digital health (2)
Diversity, equity & inclusion (9)
Drug discovery (34)
Drug pricing (9)
Drug shortages (3)
Duchenne muscular dystrophy (31)
Earnings (11054)
Editorial (6)
Employer branding (7)
Employer resources (33)
Events (22410)
Executive appointments (215)
FDA (2817)
Featured Employer (14)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (219)
Gene editing (36)
Generative AI (8)
Gene therapy (79)
GLP-1 (170)
Government (909)
Guidances (12)
Healthcare (3869)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (22)
Indications (8)
Infectious disease (729)
Inflammatory bowel disease (45)
Influenza (10)
Intellectual property (20)
Interviews (34)
IPO (2036)
IRA (5)
Job creations (623)
Job search strategy (201)
Kidney cancer (2)
Labor market (7)
Layoffs (88)
Leadership (4)
Legal (880)
Liver cancer (14)
Lung cancer (74)
Lymphoma (36)
Machine learning (1)
Management (11)
Manufacturing (49)
MASH (22)
Medical device (1794)
Medtech (1796)
Mergers & acquisitions (3282)
Metabolic disorders (162)
Multiple sclerosis (17)
NASH (5)
Neurodegenerative disease (26)
Neuropsychiatric disorders (7)
Neuroscience (686)
NextGen: Class of 2025 (1273)
Non-profit (1395)
Northern California (583)
Now hiring (5)
Obesity (83)
Opinion (48)
Ovarian cancer (12)
Pain (16)
Pancreatic cancer (15)
Parkinson's disease (48)
Partnered (5)
Patents (38)
Patient recruitment (25)
Peanut (9)
People (18041)
Pharmaceutical (8)
Phase I (4930)
Phase II (6992)
Phase III (5785)
Pipeline (285)
Podcasts (3)
Policy (20)
Postmarket research (663)
Preclinical (3193)
Press Release (33)
Prostate cancer (25)
Psychedelics (11)
Radiopharmaceuticals (48)
Rare diseases (102)
Real estate (1214)
Recruiting (15)
Regulatory (3859)
Reports (8)
Research institute (1023)
Resumes & cover letters (23)
Rett syndrome (1)
RNA editing (1)
RSV (5)
Schizophrenia (17)
Series A (57)
Series B (17)
Sickle cell disease (23)
Southern California (468)
Special edition (1)
Spinal muscular atrophy (66)
Sponsored (13)
Startups (1180)
State (1)
Stomach cancer (3)
Supply chain (7)
The Weekly (2)
United States (5216)
Vaccines (130)
Venture capitalists (8)
Webinars (2)
Weight loss (36)
Women's health (7)
Worklife (2)
Date
Today (34)
Last 7 days (192)
Last 30 days (751)
Last 365 days (8520)
2025 (1963)
2024 (8870)
2023 (10131)
2022 (12898)
2021 (14119)
2020 (12483)
2019 (10036)
2018 (7698)
2017 (7858)
2016 (7576)
2015 (8161)
2014 (5961)
2013 (4756)
2012 (4881)
2011 (5147)
2010 (4329)
Location
Africa (162)
Alabama (12)
Alaska (4)
Arizona (31)
Arkansas (2)
Asia (7938)
Australia (1348)
California (1271)
Canada (491)
China (94)
Colorado (65)
Connecticut (67)
Delaware (30)
Europe (21936)
Florida (153)
Georgia (47)
Idaho (9)
Illinois (92)
India (1)
Indiana (52)
Iowa (1)
Japan (33)
Kansas (11)
Kentucky (4)
Louisiana (2)
Maine (37)
Maryland (157)
Massachusetts (1180)
Michigan (71)
Minnesota (58)
Missouri (20)
Montana (5)
Nebraska (6)
Nevada (11)
New Hampshire (14)
New Jersey (362)
New Mexico (21)
New York (474)
North Carolina (208)
North Dakota (2)
Northern California (583)
Ohio (65)
Oklahoma (6)
Oregon (19)
Pennsylvania (304)
Puerto Rico (2)
Rhode Island (12)
South America (195)
South Carolina (2)
Southern California (468)
Tennessee (17)
Texas (219)
Utah (63)
Virginia (28)
Washington D.C. (8)
Washington State (132)
Wisconsin (12)
144,605 Results for "gaumard scientific".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Gaumard Scientific Announces First Installation of Robotic Patient Simulator with Conversational Speech, HAL® S5301, at Emory Nursing Learning Center
Gaumard Scientific Co. announced that HAL® S5301, the world’s most advanced interdisciplinary patient simulator, has been installed at the Emory University Nell Hodgson Woodruff School of Nursing’s new state-of-the-art simulation and learning center.
November 14, 2022
·
5 min read
Gaumard Scientific to Unveil the World’s Most Advanced Multidisciplinary Patient Simulator, HAL® S5301
Gaumard Scientific Co., an industry leader of simulation technology for healthcare education and training, today announced that HAL® S5301, the world’s most advanced multidisciplinary patient simulator, will be introduced at the International Meeting on Simulation in Healthcare (IMSH), January 15-19, at the Los Angeles Convention Center, booth #311.
January 14, 2022
·
3 min read
BioMidwest
Gaumard Scientific’s New Mixed Reality Training Solution, Obstetric MR™ for VICTORIA® is a Finalist in Fast Company’s 2021 Innovation by Design Awards
Gaumard Scientific Co., an industry leader of simulation technology for healthcare education and training, announced that Obstetric MR™ for VICTORIA® was honored in Fast Company’s Innovation by Design Awards for 2021 in the Learning category.
September 24, 2021
·
5 min read
Press Releases
Braxia Scientific Update
February 20, 2025
·
3 min read
Press Releases
Immunic, Inc. to Participate in Scientific and Industry Conferences in April
April 1, 2025
·
5 min read
Press Releases
Madison Scientific Closes $7M in Seed Financing
March 19, 2025
·
3 min read
Press Releases
Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program
March 26, 2025
·
2 min read
Press Releases
Immunic to Participate in Scientific and Investor Conferences in March
March 3, 2025
·
6 min read
Press Releases
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
March 20, 2025
·
3 min read
Press Releases
Scientific Industries to Host Fiscal Year 2024 Financial Results Investor Call on April 1, 2025
April 1, 2025
·
2 min read
1 of 14,461
Next
